|drug655||Chloroquine Diphosphate Wiki||1.00|
|drug2161||Placebo oral tablet Wiki||0.18|
|D045169||Severe Acute Respiratory Syndrome NIH||0.05|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
During the new COVID-19 pandemic physicians all over the world have faced different challenges .Oxidative stress is a probable cause of multi organ failure in this setting which never has been evaluated in COVID-19 infection to the best of knowledge.Present study aimed to evaluate oxidative stress marker and redox system status in different COVID-19 patients regarding the severity of involvement.
Description: MDA x 2 ULN in severe COVIDMeasure: MDA concentration Time: 2 weeks
Description: Difference between severe and controlsMeasure: Biopterin concentration Time: 2 weeks
Description: Difference between severe and controlsMeasure: Neopterin rate of increase Time: 2 weeks